Sonus Pharma (SNUS) ? Opinions Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sonus Pharma (SNUS) ? Opinions

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: (no name provided) who wrote (276)	3/30/1998 9:03:00 PM
From: (no name provided)	Read Replies (1) of 384

Prediction correct!! SNUS fails to mention that they did not get approval for radiology. Last weeks press release: "EchoGen(R) is the Company's proprietary ultrasound contrast agent being investigated for use in cardiology and radiology applications" But the EMEA only approved cardiology. Not a word about radiology in the SNUS press release. This is classic SNUS behavior. Ignore the bad news or bury it in some good news. Kafka666

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next